Pharma Times

article thumbnail

PMLiVE’s T40 – open for submissions!

Pharma Times

Healthcare agencies can submit their entries free of charge with a deadline of 30 April

70
article thumbnail

University of Liverpool to lead £125m research facility supported by UKRI investment

Pharma Times

Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Strand Therapeutics develops new class of mRNA molecules for cancer

Pharma Times

The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases

article thumbnail

LifeArc provides £750,000 fund for clinical trial to treat neuroferritinopathy

Pharma Times

The progressive and incurable brain disorder currently affects approximately 100 patients worldwide

article thumbnail

Researchers identify group of biological markers found in high levels in TB patients

Pharma Times

According to the World Health Organization, TB is responsible for over one million annual deaths

Research 112
article thumbnail

Innovate UK awards ten projects over £6m to develop new clinical tools for dementia

Pharma Times

Dementia is estimated to affect 850,000 people in the UK and costs the nation around £23bn a year

article thumbnail

Researchers suggest treatments for rare diseases could reduce burden of kidney disease

Pharma Times

Rare kidney diseases are a group of conditions which account for over 5% of people living with chronic kidney disease

Research 143